Analysts expect UNITED THERAPEUTICS Corp to report revenue of 807.01 M for Q3 26, against a range of 754.01 M to 860.02 M. The most recent reported quarter, Q2 26, came in at 783.30 M, a 5.6% miss against the 830.05 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 748.90 M | 735.90 M | 794.40 M | 798.60 M | 799.50 M | 790.20 M | 781.50 M | 783.30 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 722.77 M | 841.80 M | 826.64 M | 888.22 M | 925.24 M | 819.81 M | 794.51 M | 871.06 M | 860.02 M | 796.26 M | 812.53 M | 768.10 M | 798.69 M | 837.72 M | 1.03 B | 955.52 M | ||||||||||
| Low Estimate | 634.54 M | 719.35 M | 715.93 M | 777.03 M | 780.42 M | 747.46 M | 699.02 M | 789.04 M | 754.01 M | 689.43 M | 716.39 M | 652.82 M | 727.67 M | 744.86 M | 961.73 M | 884.19 M | ||||||||||
| Consensus Estimate | 678.65 M | 780.58 M | 771.29 M | 832.62 M | 852.83 M | 783.63 M | 746.76 M | 830.05 M | 807.01 M | 742.85 M | 764.46 M | 710.46 M | 763.18 M | 791.29 M | 996.72 M | 919.86 M |
Analysts expect UNITED THERAPEUTICS Corp to report earnings per share of 6.61 for Q3 26, against a range of 6.04 to 7.18. The most recent reported quarter, Q2 26, came in at 7.27, a 12.2% beat against the 6.48 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 6.39 | 6.19 | 6.63 | 6.41 | 7.16 | 7.70 | 5.82 | 7.27 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 6.42 | 6.26 | 7.36 | 7.46 | 7.39 | 7.27 | 7.00 | 7.04 | 7.18 | 6.85 | 7.12 | 7.17 | 7.42 | 7.67 | 8.58 | 9.21 | ||||||||||
| Low Estimate | 6.00 | 5.74 | 6.62 | 6.38 | 6.27 | 6.27 | 6.40 | 5.92 | 6.04 | 5.97 | 6.34 | 6.37 | 6.88 | 7.07 | 7.72 | 8.13 | ||||||||||
| Consensus Estimate | 6.21 | 6.00 | 6.99 | 6.92 | 6.83 | 6.77 | 6.70 | 6.48 | 6.61 | 6.41 | 6.73 | 6.77 | 7.15 | 7.37 | 8.15 | 8.67 |
Pull Wall Street consensus for UNITED THERAPEUTICS Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=UTHR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "UTHR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=UTHR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();